| Code | 5693D | ||||||||||
| MA number | 16/0221/20-S | ||||||||||
| Product Form: | tbl flm 14x5 mg (blis.Al/PVC/PVDC) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Zaklady Farmaceutyczne POLPHARMA S.A., Poland | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister Al/PVC/PVDC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 20.10.2020 |
| SPC: |
SPC_Polapix 5 mg filmom obalené tablety_03.2024.pdf
|
| PIL: |
PIL_Polapix 5 mg filmom obalené tablety_03.2024.pdf
|
| Safety feature | Yes |
| Data update: | 21.05.2025 |
